As of Feb 10
| -0.0061 / -3.11%|
The 1 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 0.65, with a high estimate of 0.65 and a low estimate of 0.65. The median estimate represents a +242.11% increase from the last price of 0.19.
The current consensus among 1 polled investment analysts is to Hold stock in Synta Pharmaceuticals Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.